Asthma Spacer Market to Surpass US$ 2.93 Bn by 2030 - Coherent Market Insights

Global Asthma Spacer Market, By Spacer Type (Volumatic, Aerochamber, InspirEase, Optichamber, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1.86 Billion in 2023 and is expected to exhibit a CAGR of 6.7% during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.

Key market players are focusing on adopting growth strategies such as the launch of new products, which will drive the global asthma spacer market. The product launch is for asthma management, and the patient having difficulty with the inhaler can resolve the issue. The new products are designed to improve the effectiveness and ease of use for asthma patients, ultimately enhancing the overall quality of life. Additionally, the adoption of innovative solutions is expected to contribute to the growth of the global asthma spacer market by addressing the specific needs and challenges faced by individuals with asthma.

Global Asthma Spacer Market: Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019, as "coronavirus disease 2019" or COVID-19. The virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of things from one place to another.

Global Asthma Spacer Market: Key Developments

In 2018, the National Asthma Council, Australia launched the latest National Asthma Strategy, which will focus on ways to reduce the impact of asthma on individuals. The council is also collaborating with Cipla in order to provide education to the people of Australia on how to use different medical devices, such as asthma spacers, to control the severity of asthma. Such collaborations will help to promote and market the company’s products and thus contribute to global asthma spacer market growth.

Browse 28 Market Data Tables and 28 Figures spread through 167 Pages and in-depth TOC on “Global Asthma Spacer Market”- Forecast to 2030, Global Asthma Spacer Market, By Spacer Type (Volumatic, Aerochamber, InspirEase, Optichamber, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/asthma-spacers-market-3020

Key Takeaways of the Global Asthma Spacer Market:

• The global asthma spacer market is expected to exhibit a CAGR of 6.7% during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the global asthma spacer market.
• Among spacer type, the volumatic segment is expected to hold a dominant position in the global asthma spacer market during the forecast period, and this is attributed to the technological advancements in the field of asthma spacers. A volumatic spacer is a large-volume spacer that is intended to make it easier for patients to use the inhaler effectively. The easy availability of asthma spacers will drive market growth over the forecast period. The spacers are designed to reduce the need for precise coordination between inhaler activation and inhalation, making them particularly useful for children or individuals with limited dexterity. Additionally, increased awareness about the benefits of using spacers in asthma management has also contributed to the growing demand for these devices in the market.
• Among region, North America is expected to be the dominant region in the global asthma spacer market, owing to its focus on organic strategies to start new product launches. More than 27 million people in the U.S. have asthma. More than 22 million U.S. adults ages 18 and older have asthma. Asthma rates are highest in Black and Indigenous American adults in the U.S. Asthma is more common in female adults than male adults. Around 10.8% of female adults have asthma, compared to 6.5% of male adults.
• Major players operating in the global asthma spacer market are Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, GlaxoSmithKline Plc., Lupin, Medical Developments International, Visiomed Group Ltd., Cipla Inc., Clement Clarke International Ltd., Rossmax International Ltd., Luckys Pharma, Mediacare Equipments (India) Pvt. Ltd., Asia Connection Co., Ltd., and Laboratoire Protecsom SAS.